Cite
MLA Citation
M. Sebert et al.. “123 AZACITIDINE (AZA) COMBINED WITH IDARUBICIN (IDA) IN HIGHER RISK MDS (HRMDS) – RESULTS OF A PHASE I/II STUDY BY THE GFM.” Leukemia research, vol. 39, no. 1, n.d., pp. S63–. http://access.bl.uk/ark:/81055/vdc_100059913363.0x000001